Skip to content

Effect of Sesame Oil (Sesamum Indicum Linn.) consumption on lipid profile in patients with dyslipidemia

Effect of Sesame Oil (Sesamum Indicum Linn.) consumption on lipid profile of patients with dyslipidemia referred to Health Heart House affiliated to Shiraz Cardiovascular Research Center.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013060913603N1
Enrollment
135
Registered
2013-08-13
Start date
2013-08-06
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperlipidemia. Disorders of lipoprotein metabolism and other lipidaemias

Interventions

Intervention 1: Control group : no intervention. Intervention 2: Intervention group:use seasame oil orally 15 grams per day for 60 days.
Treatment - Other
Intervention group:use seasame oil orally 15 grams per day for 60 days

Sponsors

Shiraz University of Midical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age 18-75 year old; Low-density lipoprotein (LDL) 130-200 or triglyceride 200-400 or High-density lipoprotein (HDL) less 50 in female and less 40 in male; non-use antilipideimic drugs; non history of renal, liver, kidney, heart and thyroid disease; non history of diabetes mellitus; non history of food allergy especially to soya, peanuts and Walnuts; non history of asthma or atopic dermatitis. Exclusion criteria: breastfeeding and pregnancy; oral contraceptive pills consumption; use of antilipideimic drugs; alcohol consumption; hospitalization during study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Total cholesterol. Timepoint: before and 2 months after intervention. Method of measurement: biochemical measurements on blood sample.;Serum Triglyceride. Timepoint: before and 2 months after intervention. Method of measurement: biochemical measurements on blood sample.;Low-density lipoprotein (LDL). Timepoint: before and 2 months after intervention. Method of measurement: biochemical measurements on blood sample.;High-density lipoprotein (HDL). Timepoint: before and 2months after intervention. Method of measurement: biochemical measurements on blood sample.

Secondary

MeasureTime frame
Diastolic Blood Pressure. Timepoint: before and 2 months after intervention. Method of measurement: before and 2 months after intervention.;Systolic Blood Pressure. Timepoint: before and 2 months after intervention. Method of measurement: before and 2 months after intervention.;Body Mass Index. Timepoint: before and 2 months after intervention. Method of measurement: before and 2 months after intervention.;Weight. Timepoint: before and 2 months after intervention. Method of measurement: before and 2 months after intervention.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMajid Barzegar

Shiraz University of Medical Sciences

barzegaram@sums.ac.ir+98 71 1233 2366

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026